Prospective study of platelet count as a prognostic marker in predicting feto-maternal outcome in gestational hypertension


  • M. Jyothsna Saisree Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
  • Shreya Alluri Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India
  • K. Kameswaramma Department of Obstetrics and Gynaecology, Narayana Medical College and Hospital, Nellore, Andhra Pradesh, India



Gestational hypertension, Preeclampsia, Fetomaternal complications, HELLP syndrome


Background: Hypertensive disorders of pregnancy are one of the leading causes of maternal and neonatal morbidity and mortality worldwide. Hypertensive disorders of pregnancy (HDP) affects approximately 5-7% of all pregnancies. The reported incidence of HDP in India ranges from 5% to 15%. These disorders form a deadly triad-in conjunction with hemorrhage and infection, in significantly contributing to maternal morbidity and mortality. Objectives were to determine the correlation between the severity of HDP and low platelet count; to analyze maternal and fetal outcomes in relation to thrombocytopenia; to aid in early diagnosis and management and to prevent complications and thereby improving maternal and fetal outcomes.

Methods: A hospital-based prospective study was conducted in women with a provisional diagnosis of gestational hypertension over a period of 18 months. The study group comprised of pregnant women who were more than 20 weeks and were subjected to detailed history: pre-obstetric history, family history, general physical examination, abdominal examination, routine laboratory investigations, and ultrasonography and Doppler.

Results: In the study, platelet count at ≤275000 cut-offs had the highest sensitivity of 52.11%, specificity of 82.76%, PPV of 88.1%, and NPV of 41.4% in predicting feto maternal complications. Platelet count at ≤275000 cut-offs had the highest sensitivity of 62.86%, specificity of 69.23%, PPV of 52.4%, and NPV of 77.6% in predicting preeclampsia.

Conclusions: From the study, it was concluded that in gestational hypertension the estimation of platelet count is thus a reliable method for early detection and management of hypertensive disorders of pregnancy. Platelet count was significantly decreased in subjects with maternal complications, fetal complications, and with respect to the severity of preeclampsia. Platelet count however had moderate validity in predicting fetomaternal complications.


Zareian Z. Hypertensive disorders of pregnancy. Int J Gynecol Obstet. 2004;87:194-8.

Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Hypertensive disorders. In: Williams Obstetrics. 24th ed. New Delhi: McGraw-Hill Education; 2014: 728-80.

Marik PE. Hypertensive disorders of pregnancy. Postgrad Med. 2009;121(2):69-76.

Peters RM, Flack JM. Hypertensive disorders of pregnancy. J Obstet Gynecol Neonatal Nurs. 2003;33(2):209-20.

Mammaro A, Carrara S, Cavaliere A, Ermito S, Dinatale A, Pappalardo EM, et al. Hypertensive disorders in pregnancy. J Prenat Med. 2009;3(1):1-5.

Chesley LC. History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol. 1984;27(4):801-20.

DeGracia PV. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int J Gynecol Obstet. 2001;72:17-23.

Loudon I. Some historical aspects of toxaemia of pregnancy. A review. BJOG. 1991;98(9):853-8.

Delić R, Stefanović M. Optimal laboratory panel for predicting preeclampsia. J Matern Neonatal Med. 2010;23(1):96-102.

Han L, Liu X, Li H, Zou J, Yang Z, Han J. Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia. PLoS One. 2014;9(12).

Cunningham FG, Lowe T, Guss S, Mason R. Erythrocyte morphology in women with severe preeclampsia and eclampsia. Preliminary observations with scanning electron microscopy. Am J Obstet Gynecol. 1985;153:358-63.

Elenbaas RM, Elenbaas JK, Cuddy PG. Evaluating the medical literature, part II: Statistical analysis. Ann Emerg Med. 1983;12:610-20.

Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: how much matters? BJOG. 2005;112:280-5.

Doğan K, Guraslan H, Senturk MB, Helvacioglu C. Can platelet count and platelet indices predict the risk and the prognosis of preeclampsia? Hypertens Pregnancy. 2015;34(4):434-42.

Dakhale GN, Hiware SK, Shinde AT, Mahatme MS. Basic biostatistics for post-graduate students. Indian J Pharmacol. 2012;44(4):435-42.

Rao PSS, Richard J. An Introduction to Biostatistics, A manual for students in health sciences. 4th ed. New Delhi: Prentice Hall of India; 2006; 86-160.

Akıl MA, Bilik MZ, Acet H, Tunç SY, Erta F, Aydın M, et al. Mean platelet volume and neutrophil lymphocyte ratio as new markers of preeclampsia severity. Kosuyolu Hear J. 2015;18(2):84-8.

Dutta DC. Pregnancy induced hypertension, text book of obstetrics including perinatology and contraception, 7th edition. New Central Book Agency (P) Limited; 2011: 219.

Cunningham FG, Leveno KJ, Bloom SL, John C. Pregnancy induced hypertension. Williams Obstetrics. 23rd ed. New York: Mc Graw- Hill; 2010: 706-56.

Ahmed Y, vanIddekinge B, Paul C, Sullivan MF, Elder MG. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia. BJOG. 1993;100:216-20.

Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2014;175:107-11.

Karateke A, Kurt RK, Baloglu A. Relation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsia. Ginekol Pol. 2015;86(5):372-5.

Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med. 2012;44:805-16.






Original Research Articles